ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,398Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 6969

$2.34M Total Retail Price of All Prescriptions

Rank: 19 out of 6969

523 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 523 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 523 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 18,175 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$115 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CALCITRIOL 832 773 10 1 240
TRAMADOL HCL 660 604 2 27
CYMBALTA 644 580 3 72
NAMENDA 633 599 4 51
SINGULAIR 612 581 5 84
ADVAIR DISKUS 607 556 6 45
LOVAZA 551 532 7 77
LIDODERM 494 461 8 75
SPIRIVA 484 454 9 66
AMLODIPINE BESYLATE 453 418 10 4
METFORMIN HCL 376 317 11 7
OMEPRAZOLE 372 328 12 6
VOLTAREN 341 338 13 105
GABAPENTIN 328 298 14 17
EXELON 327 327 15 157
ABILIFY 316 295 16 173
CELEBREX 315 265 17 67
MECLIZINE HCL 308 280 18 100
PROAIR HFA 305 271 19 33
NEXIUM 293 279 20 52
SIMVASTATIN 283 244 21 1
FLUTICASONE PROPIONATE 283 265 21 24
HYDROCODONE-ACETAMINOPHEN 268 162 S3 23 3
ZETIA 250 247 24 98
DONEPEZIL HCL 216 210 25 32
SYMBICORT 215 214 26 149
ZOLPIDEM TARTRATE 204 170 27 16
DIOVAN HCT 201 201 28 57
PLAVIX 187 183 29 68
JANUVIA 187 170 29 41
FUROSEMIDE 187 180 29 10
CRESTOR 184 164 32 39
ATENOLOL 170 161 33 9
BENAZEPRIL HCL 169 146 34 18
LANTUS 162 124 35 50
MELOXICAM 161 148 36 36
TRIAMCINOLONE ACETONIDE 160 139 37 55
DIOVAN 157 147 38 26
RANITIDINE HCL 150 129 39 46
ATORVASTATIN CALCIUM 149 127 40 11
ACTOS 142 131 41 61
METOPROLOL TARTRATE 132 95 42 13
MONTELUKAST SODIUM 126 109 43 151
VENTOLIN HFA 126 125 43 125
TIZANIDINE HCL 122 118 45 298
ACTONEL 120 97 46 115
HYDROCHLOROTHIAZIDE 120 108 46 8
METOCLOPRAMIDE HCL 119 102 48 136
FAMOTIDINE 116 103 49 37
LEVOTHYROXINE SODIUM 113 89 50 5
LYRICA 100 99 51 137
CARVEDILOL 95 88 52 25
GLIMEPIRIDE 94 85 53 44
TAMSULOSIN HCL 92 89 54 23
CARBIDOPA-LEVODOPA 90 88 55 119
NASONEX 89 63 56 144
BYSTOLIC 86 86 57 155
TRAZODONE HCL 84 60 58 47
LIPITOR 83 78 59 89
METOLAZONE 82 82 60 322
SEROQUEL 81 75 61 205
ALENDRONATE SODIUM 78 78 62 14
CLONIDINE HCL 76 65 63 59
LOSARTAN POTASSIUM 75 65 64 12
LISINOPRIL 74 50 65 2
PATANASE 73 61 66 543
TERAZOSIN HCL 71 68 67 49
COLESTIPOL HCL 70 48 68 409
WARFARIN SODIUM 68 67 69 20
ALLOPURINOL 65 63 70 35
PATANOL 65 64 70 142
SPIRONOLACTONE 65 65 70 102
FENOFIBRATE 64 60 73 63
INSULIN SYRINGE 64 57 73 60
LEXAPRO 64 63 73 200
ACIPHEX 63 48 76 181
NOVOLIN 70-30 61 59 77 315
PROVENTIL HFA 58 46 78 431
AVODART 57 55 79 108
BENICAR HCT 56 56 80 176
BENICAR 56 53 80 107
CARISOPRODOL 55 0 R 82 69
CLOPIDOGREL 55 50 82 48
MIRTAZAPINE 54 44 84 76
BONIVA 52 45 85 198
BUSPIRONE HCL 51 39 86 187
LUNESTA 51 13 86 374
PANTOPRAZOLE SODIUM 51 40 86 31
ENALAPRIL MALEATE 50 47 89 56
LOSARTAN-HYDROCHLOROTHIAZIDE 50 47 89 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.